Cryphorchidism reproductive system phisiology long question

Reading File
Now let me search the medical library in parallel for cryptorchidism content.
Finding Sources
Finding Sources
Finding Sources
Excellent - multiple rich sources found. Let me read the most comprehensive ones in parallel.
Reading File
Reading File
Reading File
Reading File
Good content. Now let me get more physiological detail - testicular descent phases, hormones, reproductive physiology aspects, and the S Das manual which typically has very exam-style content.
Reading File
Finding Sources
Reading File
Excellent - I now have rich content. Let me get the key physiology detail from Campbell Walsh and also fetch the embryology diagram.
Reading File
Loading Image
I now have comprehensive content from multiple authoritative textbooks. Let me compile the full long-answer response.

Cryptorchidism: Reproductive System Physiology - Long Answer

Definition

Cryptorchidism (Greek: kryptos = hidden, orchis = testis) is the failure of one or both testes to descend from the abdominal cavity into the scrotal sac. It is the most common congenital anomaly of the male genitalia and a significant cause of male infertility and testicular malignancy.

Embryology and Normal Testicular Descent

Origin of the Testis

  • At ~32 days postovulation, gonads arise as thickenings on the medial aspect of the urogenital ridge (posterior abdominal wall)
  • The SRY gene (sex-determining region, Y chromosome) triggers testicular differentiation - it activates SOX9, which drives Sertoli cell specification
  • By 6-8 weeks, primordial germ cells (PGCs) migrate from the yolk sac and localize within forming testicular cords
  • Leydig cells appear in the interstitium by weeks 8-10 and begin testosterone secretion under hCG stimulation

Two Phases of Testicular Descent

(Robbins, Cotran & Kumar Pathologic Basis of Disease)
Phase 1 - Transabdominal Phase (weeks 10-15):
  • The testes migrate from the posterior abdominal wall to the lower abdomen/pelvic brim
  • Controlled by Müllerian-inhibiting substance (MIS)/Anti-Müllerian Hormone (AMH) secreted by Sertoli cells
  • The gubernaculum (a fibromuscular band) swells and anchors the testis to the inguinal region, while the cranial suspensory ligament regresses
  • INSL3 (insulin-like factor 3, produced by Leydig cells) acting via its receptor RXFP2/LGRF8 is critical for gubernacular swelling and anchoring in this phase
Phase 2 - Inguinoscrotal Phase (weeks 25-35, third trimester):
  • The testis passes through the inguinal canal into the scrotum
  • This phase is androgen-dependent - testosterone (converted to DHT) acts via the androgen receptor
  • Androgens are required to induce regression of the cranial suspensory ligament and drive gubernacular elongation/migration
  • The genitofemoral nerve (GFN) provides essential innervation to the gubernaculum; calcitonin gene-related peptide (CGRP) released from GFN is the downstream mediator
  • Complete descent into the scrotum is not achieved until the third trimester
Key hormonal regulators: INSL3 (Phase 1) + Androgens/DHT (Phase 2)
(Campbell Walsh Wein Urology)

Epidemiology

ParameterData
Premature infants~30% affected at birth
Full-term infants3-5% at birth; ~1% by 1 year of age
Unilateral vs bilateralUnilateral ~2x more common than bilateral
Bilateral accounts for~25% of cases
Spontaneous descentMost inguinal UDT descend by end of Year 1
(The Developing Human; Robbins & Kumar)

Classification

1. Undescended Testis (True Cryptorchidism)
  • Testis arrested along its normal path of descent
  • Locations in order of frequency (see figure below):
    1. Inguinal canal (most common, ~70%)
    2. Just inside the deep inguinal ring
    3. Just outside the superficial inguinal ring
    4. High scrotal
2. Ectopic Testis
  • Testis has deviated from the normal path of descent after exiting the inguinal canal
  • Sites: superficial inguinal pouch (most common), perineum, root of penis (pubic type), femoral triangle
  • Due to rupture/dominance of an accessory tail of the gubernaculum (Lockwood's five tails: scrotal, pubic, perineal, inguinal, femoral)
  • An ectopic testis is usually well-developed (unlike an undescended testis, which is small and atrophied)
3. Retractile Testis
  • A normally descended testis that retracts into the inguinal canal due to hyperactive cremasteric reflex
  • Can be manually brought into the scrotum - does NOT require surgery
Positions of cryptorchid testes (numbered 1-4 in order of frequency) and ectopic testis positions
Fig. Possible sites of cryptorchid (A) and ectopic (B) testes. (The Developing Human, Moore & Persaud)

Pathophysiology and Consequences

Why the Scrotum Matters - Thermoregulation

Normal spermatogenesis requires a temperature 2-4°C below core body temperature (33-35°C). The scrotum achieves this via:
  • Pampiniform plexus (countercurrent heat exchange)
  • Cremaster muscle (temperature-regulated elevation/lowering)
  • Dartos muscle and thin scrotal skin
In cryptorchidism, the retained testis is exposed to normal abdominal temperature (~37°C), which is toxic to the germinal epithelium (spermatogonia are heat-sensitive) while Leydig cells are relatively spared.

Histological Changes (Robbins, Cotran & Kumar)

TimelineHistological Change
At birthUsually normal
By 2 yearsBasement membrane thickening of seminiferous tubules
ProgressiveLoss of spermatogonia; tubules contain only Sertoli cells
Late stageHyalinized tubular cords; increased interstitial stroma
Any stageGerm cell neoplasia in situ (GCNIS) may appear
ThroughoutLeydig cells are SPARED → testosterone production relatively preserved
Notably, similar histologic changes may appear in the contralateral normally descended testis in unilateral cryptorchidism - suggesting an underlying intrinsic gonadal developmental defect (testicular dysgenesis syndrome) rather than purely positional damage.

Etiology and Risk Factors

Hormonal causes:
  • Deficiency of fetal testosterone or DHT production
  • Deficiency of INSL3 or RXFP2 mutations
  • Deficiency of AMH/MIS
Genetic/syndromic associations:
  • Prader-Willi syndrome
  • Noonan syndrome
  • Androgen insensitivity syndromes
  • HOX gene mutations
Environmental factors:
  • Endocrine disruptors (estrogen-like compounds in the intrauterine environment)
  • Twin studies suggest both maternal inheritance and intrauterine environment play roles
Most cases: etiology unknown (cryptorchidism is rarely associated with a well-defined hormonal disorder in clinical practice)

Clinical Features

  • Asymptomatic - usually discovered by parent or physician noting an empty scrotum
  • Unilateral > bilateral
  • The undescended testis is smaller and less developed than the contralateral testis
Complications:
ComplicationDetails
Infertility/subfertilityDue to impaired spermatogenesis (Sertoli cell dysfunction, heat damage)
Testicular malignancy4-10 fold increased risk (most common: seminoma)
Testicular torsionUndescended testis frequently undergoes torsion - mimics strangulated hernia
Inguinal hernia10-20% of cryptorchid patients (patent processus vaginalis)
PsychologicalEmpty scrotum in older children

Reproductive Prognosis

(Campbell Walsh Wein Urology)
ConditionPaternity RateInhibin BSperm Density
Normal controls~96%NormalNormal
Unilateral cryptorchidism (treated)~96%~2/3 of normalReduced
Bilateral cryptorchidism (treated)~70%~1/3 of normalMarkedly reduced
  • Fertility impairment in cryptorchidism is primarily due to Sertoli cell/seminiferous epithelium dysfunction (reflected by low inhibin B), rather than Leydig cell dysfunction (testosterone levels less severely affected)
  • Bilateral cryptorchidism carries a significantly worse prognosis for fertility than unilateral

Diagnosis

Physical examination - primary tool:
  • Examine in warm room; supine and frog-leg position; palpate inguinal canal and scrotum
  • Palpable vs non-palpable testis guides management
Investigations:
  • Ultrasound - for inguinal testes
  • MRI - for suspected intra-abdominal testis
  • Laparoscopy - gold standard for non-palpable testis (diagnostic and therapeutic)
  • Hormonal stimulation test (hCG stimulation): rise in testosterone confirms functional testicular tissue; no response suggests absent testes (anorchia)
  • FSH, LH, inhibin B - markers of Sertoli cell and spermatogenesis status

Treatment

Medical (Hormonal)

  • hCG injections (human chorionic gonadotropin) - stimulates Leydig cells to produce testosterone, promoting descent
  • GnRH (buserelin) intranasal - less commonly used
  • Success rate is modest (~20-30%); not recommended as primary treatment by modern guidelines

Surgical - Orchidopexy (Definitive Treatment)

  • Timing: Current recommendation = 6 to 12 months of age (before histologic changes become established)
    • Sabiston: orchidopexy at 6-12 months for palpable inguinal testis
    • Robbins: "hormone injections followed by early orchiopexy at 6-12 months if medical treatment fails"
Procedure:
  1. Standard dartos pouch orchidopexy - for palpable inguinal testis; testis brought down and fixed in a sub-dartos pouch in the scrotum
  2. Two-stage Fowler-Stephens orchidopexy - for high intraabdominal testis with short vessels:
    • Stage 1: Ligation of testicular vessels (to allow collateral circulation to develop over 6 months)
    • Stage 2: Orchidopexy via collateral blood supply
  3. Laparoscopic orchidopexy - increasingly preferred single-stage option for intra-abdominal testis

Outcomes of Orchidopexy

  • Reduces (but does not eliminate) risk of malignancy
  • Reduces risk of torsion
  • Improves fertility outcomes if performed early
  • Deficient spermatogenesis still reported in 10-60% even after orchidopexy
  • Cancer risk remains elevated even after repositioning (linked to intrinsic testicular dysgenesis)

Relationship to Testicular Cancer

  • Cryptorchidism is the most important risk factor for testicular germ cell tumors
  • Risk is highest with abdominal cryptorchidism (>intra-canalicular)
  • Mechanism: Germ cell neoplasia in situ (GCNIS) - malignant transformation of arrested spermatogonia/gonocytes
  • The contralateral descended testis is also at higher risk for malignancy - supporting the testicular dysgenesis theory
  • Most common tumor arising: seminoma
  • Orchidopexy does NOT eliminate the cancer risk but does allow regular physical examination and earlier detection

Summary Table

FeatureKey Point
DefinitionFailure of testis to descend into scrotum
Incidence3-5% at birth; 1% at 1 year
Phase 1 hormoneINSL3 + AMH (transabdominal)
Phase 2 hormoneAndrogens/DHT (inguinoscrotal)
Most common siteInguinal canal
PathologySpermatogonia lost; Leydig cells spared
ComplicationsInfertility, malignancy, torsion, hernia
Treatment timingOrchidopexy at 6-12 months
Cancer risk4-10x increased risk
Fertility (bilateral)~70% paternity rate after treatment

Sources: Robbins, Cotran & Kumar Pathologic Basis of Disease | Robbins & Kumar Basic Pathology | Campbell Walsh Wein Urology | The Developing Human: Clinically Oriented Embryology (Moore & Persaud) | Sabiston Textbook of Surgery | S Das Manual on Clinical Surgery
This is a shared conversation. Sign in to Orris to start your own chat.